About Forward

Over a 5-year period, Gedeon Richter will invest €1 million in research grants for innovative research programmes to improve fertility treatments to the benefit of patients seeking to become parents. The grants will be awarded to the host institution, which will take on the management of the fund to support the research study.

Who is eligible to apply for a FORWARD Grant?

Researchers and clinical institutions may apply for a grant if they are involved in innovative research projects that may improve fertility treatments to the benefit of patients seeking to become parents.

How to apply

Applications for the 2020 FORWARD Grant Awards are now closed.

You can download the application here.

Complete the application form in English and email it to: [email protected]

Please make sure to:

  • Attach a brief CV of the lead investigator
  • Include your institution and country in the subject box

If you have any questions on how to apply, please email: [email protected]

Closing and review dates for applications

The application closing date was 16 November 2019. After a series of reviews, shortlisted applicants will be notified and may be asked to provide further details. The successful applicants are then contacted confidentially and the public announcement of winners will be made at ESHRE 2020 in Copenhagen.

Research reporting

Successful applicants and their research teams will be required through the course of their work to submit progress reports associated with the achievement of agreed milestones.

If the research team submits the research for publication in a peer-reviewed journal or presentation at a medical congress, Gedeon Richter asks to be informed prior to submission and/or publication.

Judging criteria

The FORWARD Scientific Committee – formed by an internal committee of reproductive endocrinologists, embryologists, clinical scientists and regulatory experts – will select potential Grant Awardees based on rigorous scientific criteria.

Each proposal will be marked across four categories:

  • Feasibility
  • Innovation/novelty
  • Contribution to improve fertility treatments to the benefit of patients
  • Added value and clear advancement of research topic